Molecularly defined subpopulations of leptin receptor neurons dissociate the control of food intake from blood pressure

This study identifies distinct subpopulations of LeprGlp1r neurons in the arcuate and dorsomedial hypothalamic nuclei that independently regulate food intake and blood pressure, respectively, revealing a molecular basis for dissociating metabolic and cardiovascular control.

The Gist

The Big Picture: The Body's "Master Control Panel"

Imagine your body is a massive, high-tech city. The hypothalamus in your brain is the City Hall. Inside City Hall, there is a specific department called the Leptin Receptor (Lepr) Division.

Leptin is a hormone secreted by your fat cells. Think of Leptin as a messenger pigeon flying into City Hall carrying a note that says, "We have plenty of food stored; stop eating and start burning energy!"

For a long time, scientists knew this division controlled two main things:

1. The Food Stop Sign: Telling you to stop eating.
2. The Energy Furnace: Telling your body to burn calories and keep your heart pumping fast (which raises blood pressure).

The mystery was: How does one group of neurons do both? Does the same neuron tell you to stop eating and speed up your heart? Or are there different teams handling these jobs?

The Discovery: Two Specialized Teams in One Office

This paper discovered that the "Leptin Division" isn't just one big, messy room. It actually consists of two distinct sub-teams living in different wings of the same building (the hypothalamus), and they have very different jobs.

The researchers found these neurons express two specific markers (like wearing two different badges): Lepr and Glp1r. They call them LeprGlp1r neurons.

Here is how they split the work:

Team 1: The "Diet Police" (Located in the ARC)

• Location: The Arcuate Nucleus (ARC).
• Job: Their only job is to stop you from eating.
• How it works: When Leptin (the messenger pigeon) arrives, this team shuts down the "hunger neurons" (Agrp neurons). It's like flipping a switch that turns off the "I'm hungry" alarm.
• Side Effects: They do not touch your heart rate or blood pressure. They are purely about food.

Team 2: The "Sympathetic Surgeons" (Located in the DMH)

• Location: The Dorsomedial Hypothalamic Nucleus (DMH).
• Job: Their only job is to rev up your engine.
• How it works: When Leptin arrives, this team turns up the heat. They make your brown fat burn calories, they make you move around more, and they tell your heart to pump harder.
• Side Effects: They do not make you stop eating. They are purely about energy expenditure and blood pressure.

The Analogy: The Car Dashboard

Imagine your body is a car.

• Leptin is the driver pressing the gas pedal.
• Team 1 (ARC) is the driver's hand on the brake pedal (stopping the car from eating more).
• Team 2 (DMH) is the driver's foot on the gas pedal (speeding up the engine and burning fuel).

Previously, scientists thought the driver used one foot to do both. This paper shows the driver actually has two separate controls: one for braking (stopping food intake) and one for accelerating (burning energy and raising blood pressure).

Why This Matters: Solving the "Obesity Paradox"

Here is the weird part that makes this discovery so important:

• People with no leptin (or broken leptin receptors) become extremely obese (because they never stop eating).
• However, these same people often have low blood pressure.

Usually, being obese makes your blood pressure go up. But because they lack leptin, the "Sympathetic Surgeons" (Team 2) never get the signal to turn up the engine. So, they are heavy, but their blood pressure is low.

The Breakthrough:
The researchers proved that if you specifically break the connection between Leptin and Team 2 (DMH), the mice get fat (because they still eat) but their blood pressure drops.

This means the "blood pressure raising" effect of leptin is separate from the "weight loss" effect.

The "Aha!" Moment: New Hope for Medicine

This discovery is like finding a remote control with two separate buttons instead of one big button.

• Current Drugs (like GLP-1 agonists/Weight loss shots): These press the "Big Button." They activate both teams. They make you stop eating (good!) but they also raise your heart rate and blood pressure (which can be a side effect for some people).
• Future Possibility: Now that we know Team 1 and Team 2 are separate, scientists might be able to design a drug that only presses the "Stop Eating" button (Team 1) without touching the "Raise Blood Pressure" button (Team 2).

Summary in Plain English

1. Leptin tells your brain to stop eating and burn energy.
2. Scientists found that the brain cells receiving this message are actually two different teams living in different neighborhoods.
3. Team A (ARC) controls hunger. When they work, you stop eating, but your blood pressure stays normal.
4. Team B (DMH) controls energy and blood pressure. When they work, you burn calories and your heart beats faster, but you don't necessarily stop eating.
5. The Takeaway: We can now imagine creating medicines that target only the hunger team to help people lose weight without the side effect of high blood pressure. This could make weight-loss treatments safer and more effective.

Technical Summary

1. Problem Statement

Leptin, a hormone secreted by adipose tissue, is known to regulate both energy balance (suppressing food intake and increasing energy expenditure) and cardiovascular function (increasing blood pressure and heart rate). While the lack of leptin signaling leads to obesity and hypotension, the specific neuronal populations mediating these distinct physiological outputs have remained undefined.

• The Gap: Previous studies identified Lepr (leptin receptor) neurons in the hypothalamus (e.g., ARC and DMH) but could not molecularly distinguish which specific subpopulations control blood pressure (BP) versus those controlling food intake.
• The Hypothesis: The authors hypothesized that Lepr-expressing neurons are not a monolithic group but consist of distinct molecularly defined subpopulations that differentially regulate feeding behavior and sympathetic nervous system (SNS) outflow (including BP).

2. Methodology

The study employed a multi-modal approach combining human genetics, single-cell genomics, spatial transcriptomics, and advanced intersectional neurocircuitry tracing in mice.

• Genetic Correlation & GWAS: The authors correlated systolic blood pressure (BP) Genome-Wide Association Study (GWAS) loci with transcriptional responses to leptin across five distinct mediobasal hypothalamic (MBH) Lepr neuron populations using existing single-nucleus RNA sequencing (snRNA-seq) data.
• Mouse Models:
  • Knockout: Generated Glp1r^Cre;Lepr^Flox/Flox (Lepr^Glp1rKO) mice to ablate Lepr specifically in Lepr^Glp1r neurons.
  • Intersectional Reporter: Created Lepr^Cre;Glp1r^Flp mice and crossed them with Rosa26^LSL-GFP and Rosa26^FSF-tdTomato reporters to generate Lepr^GFP;Glp1r^tdT mice for specific identification of Lepr^Glp1r neurons.
  • New Allele: Generated a Glp1r^Flpo mouse line using CRISPR/Cas9 to enable Flp-recombinase-based intersectional genetics.
• Single-Cell & Spatial Transcriptomics:
  • Performed snRNA-seq on hypothalamic nuclei from Lepr^Cre;Rosa26^Sun1-sfGFP mice to identify distinct Lepr neuron clusters.
  • Utilized Xenium spatial transcriptomics to map the anatomical distribution of identified subpopulations.
• Circuit Tracing:
  • Retrograde: Developed a RADRR (Rabies Dual Recombinase Retrograde) tracing system requiring both Cre and Flp recombinases to map inputs specifically to Lepr^Glp1r neurons.
  • Anterograde: Used the tTARGIT system (tetracycline transactivator-driven intersectional targeting) to express Channelrhodopsin-2 (ChR2) in specific subpopulations to map downstream projections.
• Functional Manipulation:
  • Used the tTARGIT system to express the excitatory DREADD (hM3Dq) specifically in Arcuate Nucleus (ARC) or Dorsomedial Hypothalamic Nucleus (DMH) Lepr^Glp1r neurons.
  • Administered Clozapine-N-oxide (CNO) to activate these neurons and measured physiological outputs (food intake, energy expenditure, BAT thermogenesis, BP, and heart rate) using telemetry and metabolic cages.

3. Key Contributions

1. Molecular Identification: Identified that Lepr^Glp1r neurons (which also express Trh and Bnc2) are not a single population but segregate into two distinct transcriptional subpopulations: Lepr^Glp1r-1 and Lepr^Glp1r-2.
2. Anatomical Segregation: Mapped these subpopulations to distinct anatomical regions:
   • Lepr^Glp1r-1: Located primarily in the Arcuate Nucleus (ARC). Marker: High Trh, Cxcl12, Ebf1-negative.
   • Lepr^Glp1r-2: Located primarily in the Dorsomedial Hypothalamus (DMH). Marker: High Ebf1, Trh-low/negative.
3. Circuit Dissection: Defined unique input and output connectivity for each subpopulation using the novel RADRR and tTARGIT systems.
4. Functional Dissociation: Demonstrated that these two subpopulations control distinct physiological outputs: one regulates feeding, the other regulates cardiovascular function.

4. Key Results

• GWAS Correlation: A significant correlation was found between systolic BP-associated GWAS genes and leptin-regulated genes specifically in Lepr^Glp1r neurons, implicating this population in BP control.
• Knockout Phenotype: Lepr^Glp1rKO mice exhibited hyperphagic obesity (increased food intake/weight) but paradoxically displayed decreased mean arterial pressure (MAP) and heart rate, confirming that Lepr^Glp1r neurons drive both feeding suppression and BP elevation.
• Subpopulation Identification: snRNA-seq revealed two distinct clusters of Lepr^Glp1r neurons. Lepr^Glp1r-1 (ARC) expresses Trh and Cxcl12, while Lepr^Glp1r-2 (DMH) expresses Ebf1.
• Circuitry Differences:
  • Inputs: Both receive overlapping inputs (e.g., PVH, VMH), but ARC neurons receive unique inputs from the VTg and MPO/BST, while DMH neurons receive distinct inputs.
  • Outputs: Both project to the ARC (specifically to inhibit Agrp neurons). However, DMH neurons uniquely project to the Raphe Pallidus (RPa), a key region for SNS outflow to the heart and brown adipose tissue (BAT). ARC neurons uniquely project to the Tuberal Nucleus (TU) and PVH.
• Functional Activation (DREADD):
  • Activating ARC Lepr^Glp1r neurons: Significantly suppressed food intake (in females) without altering energy expenditure, BAT thermogenesis, or blood pressure/heart rate.
  • Activating DMH Lepr^Glp1r neurons: Significantly increased energy expenditure, locomotor activity, BAT thermogenesis, and blood pressure/heart rate without altering food intake.
• Time Course: DMH activation rapidly increased SNS parameters (within 1 hour), whereas ARC-mediated feeding suppression took longer (4–6 hours).

5. Significance

• Mechanistic Insight: This study resolves the long-standing question of how leptin can simultaneously regulate body weight and blood pressure. It proves that these functions are mediated by anatomically and molecularly distinct subpopulations of the same receptor-expressing neuron type.
• Therapeutic Implications: The dissociation of feeding control from cardiovascular control suggests a new therapeutic avenue. Current GLP-1 receptor agonists (like semaglutide) activate both subpopulations, which may limit their efficacy or cause side effects (e.g., hypertension in some contexts). Targeting ARC Lepr^Glp1r neurons specifically could treat obesity without affecting blood pressure, while targeting DMH Lepr^Glp1r neurons could potentially treat hypotension or metabolic syndrome components without altering appetite.
• Methodological Advance: The development of the RADRR and tTARGIT systems provides a powerful toolkit for dissecting complex, intermingled neuronal populations using intersectional genetics, applicable to future studies of other hypothalamic circuits.

In summary, the paper defines a precise neural architecture where leptin's pleiotropic effects are segregated: ARC Lepr^Glp1r-1 neurons control food intake, while DMH Lepr^Glp1r-2 neurons control sympathetic tone and blood pressure.